Filing step-change
VIVOBIOT · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-20 · Evidence medium
VIVOBIOT experienced a standard shift in its financial performance, driven by accelerating trends in key metrics.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 84.62 % | 10.65 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 10.65 % | -5.19 | ▲ |
| REVENUE_GROWTH_YOY | 14.1 % | -89.2 | ▲ |
Cite this
Source: Samhati filing step-change for VIVOBIOT (2026-10). Observation: VIVOBIOT experienced a standard shift in its financial performance, driven by accelerating trends in key metrics. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/vivobiot/q/2026-10
Other periods